Treatment Patterns and Costs among Patients with OAB Treated with Combination Oral Therapy, Sacral Nerve Stimulation, Percutaneous Tibial Nerve Stimulation, or Onabotulinumtoxina in the United States.
Neurourology and urodynamics（2020）
Abstract
Treatment patterns and costs were characterized among patients with overactive bladder (OAB) receiving later‐line target therapies (combination mirabegron/antimuscarinic, sacral nerve stimulation [SNS], percutaneous tibial nerve stimulation [PTNS], or onabotulinumtoxinA).
MoreTranslated text
Key words
combination mirabegron,antimuscarinic therapy,costs and resource utilization,onabotulinumtoxinA,overactive bladder,percutaneous tibial nerve stimulation,sacral nerve stimulation
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined